383 related articles for article (PubMed ID: 18781191)
1. PTEN hamartoma tumor syndromes.
Blumenthal GM; Dennis PA
Eur J Hum Genet; 2008 Nov; 16(11):1289-300. PubMed ID: 18781191
[TBL] [Abstract][Full Text] [Related]
2. [Cowden syndrome, or multiple hamartomatous tumor syndrome, in clinical endocrinology].
Sardinoux M; Raingeard I; Bessis D; Coupier I; Renard E; Bringer J
Ann Endocrinol (Paris); 2010 Sep; 71(4):264-73. PubMed ID: 20627233
[TBL] [Abstract][Full Text] [Related]
3. PTEN hamartomatous tumor syndromes (PHTS): rare syndromes with great relevance to common cancers and targeted drug development.
Lopiccolo J; Ballas MS; Dennis PA
Crit Rev Oncol Hematol; 2007 Sep; 63(3):203-14. PubMed ID: 17643312
[TBL] [Abstract][Full Text] [Related]
4. PTEN-opathies: from biological insights to evidence-based precision medicine.
Yehia L; Ngeow J; Eng C
J Clin Invest; 2019 Feb; 129(2):452-464. PubMed ID: 30614812
[TBL] [Abstract][Full Text] [Related]
5. Hamartoma-like lesions in the mouse retina: an animal model of
Tachibana N; Touahri Y; Dixit R; David LA; Adnani L; Cantrup R; Aavani T; Wong RO; Logan C; Kurek KC; Schuurmans C
Dis Model Mech; 2018 May; 11(5):. PubMed ID: 29716894
[No Abstract] [Full Text] [Related]
6. The gene dosage of class Ia PI3K dictates the development of PTEN hamartoma tumor syndrome.
Wang Q; Weisberg E; Zhao JJ
Cell Cycle; 2013 Dec; 12(23):3589-93. PubMed ID: 24131925
[TBL] [Abstract][Full Text] [Related]
7. Long-term treatment of cancer-prone germline PTEN mutant mice with low-dose rapamycin extends lifespan and delays tumour development.
Tibarewal P; Rathbone V; Constantinou G; Pearce W; Adil M; Varyova Z; Folkes L; Hampson A; Classen GAE; Alves A; Carvalho S; Scudamore CL; Vanhaesebroeck B
J Pathol; 2022 Dec; 258(4):382-394. PubMed ID: 36073856
[TBL] [Abstract][Full Text] [Related]
8. Germline PIK3CA and AKT1 mutations in Cowden and Cowden-like syndromes.
Orloff MS; He X; Peterson C; Chen F; Chen JL; Mester JL; Eng C
Am J Hum Genet; 2013 Jan; 92(1):76-80. PubMed ID: 23246288
[TBL] [Abstract][Full Text] [Related]
9. PTEN loss in the continuum of common cancers, rare syndromes and mouse models.
Hollander MC; Blumenthal GM; Dennis PA
Nat Rev Cancer; 2011 Apr; 11(4):289-301. PubMed ID: 21430697
[TBL] [Abstract][Full Text] [Related]
10. PTEN lipid phosphatase activity and proper subcellular localization are necessary and sufficient for down-regulating AKT phosphorylation in the nucleus in Cowden syndrome.
He X; Saji M; Radhakrishnan D; Romigh T; Ngeow J; Yu Q; Wang Y; Ringel MD; Eng C
J Clin Endocrinol Metab; 2012 Nov; 97(11):E2179-87. PubMed ID: 22962422
[TBL] [Abstract][Full Text] [Related]
11. Beta catenin and cytokine pathway dysregulation in patients with manifestations of the "PTEN hamartoma tumor syndrome".
Galatola M; Paparo L; Duraturo F; Turano M; Rossi GB; Izzo P; De Rosa M
BMC Med Genet; 2012 Apr; 13():28. PubMed ID: 22520842
[TBL] [Abstract][Full Text] [Related]
12. Mutation-positive and mutation-negative patients with Cowden and Bannayan-Riley-Ruvalcaba syndromes associated with distinct 10q haplotypes.
Pezzolesi MG; Li Y; Zhou XP; Pilarski R; Shen L; Eng C
Am J Hum Genet; 2006 Nov; 79(5):923-34. PubMed ID: 17033968
[TBL] [Abstract][Full Text] [Related]
13. Germline PTEN promoter mutations and deletions in Cowden/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathway.
Zhou XP; Waite KA; Pilarski R; Hampel H; Fernandez MJ; Bos C; Dasouki M; Feldman GL; Greenberg LA; Ivanovich J; Matloff E; Patterson A; Pierpont ME; Russo D; Nassif NT; Eng C
Am J Hum Genet; 2003 Aug; 73(2):404-11. PubMed ID: 12844284
[TBL] [Abstract][Full Text] [Related]
14. Cowden syndrome: report of two cases with immunohistochemical analysis for PTEN expression.
Zabetian S; Mehregan D
Am J Dermatopathol; 2012 Aug; 34(6):632-4. PubMed ID: 22481496
[TBL] [Abstract][Full Text] [Related]
15. PTEN Mouse Models of Cancer Initiation and Progression.
Lee YR; Pandolfi PP
Cold Spring Harb Perspect Med; 2020 Feb; 10(2):. PubMed ID: 31570383
[TBL] [Abstract][Full Text] [Related]
16. Rapamycin treatment for a child with germline PTEN mutation.
Marsh DJ; Trahair TN; Martin JL; Chee WY; Walker J; Kirk EP; Baxter RC; Marshall GM
Nat Clin Pract Oncol; 2008 Jun; 5(6):357-61. PubMed ID: 18431376
[TBL] [Abstract][Full Text] [Related]
17. Small integral membrane protein 10 like 1 downregulation enhances differentiation of adipose progenitor cells.
Nebe M; Kehr S; Schmitz S; Breitfeld J; Lorenz J; Le Duc D; Stadler PF; Meiler J; Kiess W; Garten A; Kirstein AS
Biochem Biophys Res Commun; 2022 May; 604():57-62. PubMed ID: 35290761
[TBL] [Abstract][Full Text] [Related]
18. Protean PTEN: form and function.
Waite KA; Eng C
Am J Hum Genet; 2002 Apr; 70(4):829-44. PubMed ID: 11875759
[TBL] [Abstract][Full Text] [Related]
19. PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome.
Marsh DJ; Kum JB; Lunetta KL; Bennett MJ; Gorlin RJ; Ahmed SF; Bodurtha J; Crowe C; Curtis MA; Dasouki M; Dunn T; Feit H; Geraghty MT; Graham JM; Hodgson SV; Hunter A; Korf BR; Manchester D; Miesfeldt S; Murday VA; Nathanson KL; Parisi M; Pober B; Romano C; Eng C
Hum Mol Genet; 1999 Aug; 8(8):1461-72. PubMed ID: 10400993
[TBL] [Abstract][Full Text] [Related]
20. Allelic imbalance, including deletion of PTEN/MMACI, at the Cowden disease locus on 10q22-23, in hamartomas from patients with Cowden syndrome and germline PTEN mutation.
Marsh DJ; Dahia PL; Coulon V; Zheng Z; Dorion-Bonnet F; Call KM; Little R; Lin AY; Eeles RA; Goldstein AM; Hodgson SV; Richardson AL; Robinson BG; Weber HC; Longy M; Eng C
Genes Chromosomes Cancer; 1998 Jan; 21(1):61-9. PubMed ID: 9443042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
